Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

Ointments: SOP for Cleaning Homogenizers – V 2.0

Posted on By

SOP for Cleaning Homogenizers – V 2.0

Procedure for Cleaning Homogenizers

Department Production/Engineering/Quality Assurance (QA)
SOP No. SOP/Ointment/052
Supersedes V 1.0
Page No. Page X of Y
Issue Date [Insert Issue Date]
Effective Date [Insert Effective Date]
Review Date [Insert Review Date]

1. Purpose

The purpose of this Standard Operating Procedure (SOP) is to define a standardized method for cleaning homogenizers post-manufacturing to prevent cross-contamination, maintain product quality, and comply with Good Manufacturing Practices (GMP).

2. Scope

This SOP applies to all personnel responsible for cleaning and sanitizing homogenizers used in the ointment manufacturing process.

3. Responsibilities

  • Production Supervisor: Ensures that homogenizer cleaning is performed as per the SOP.
  • Machine Operator: Conducts preliminary rinsing and prepares the homogenizer for cleaning.
  • Cleaning Personnel: Executes the detailed cleaning procedure.
  • Quality Assurance (QA) Personnel: Inspects and approves the cleanliness of the homogenizer.
See also  Ointments: SOP for Conducting On-the-Spot Microbial Testing - V 2.0

4. Accountability

The Production and QA Managers are accountable for ensuring that homogenizer cleaning procedures are properly followed and documented.

5. Procedure

5.1 Pre-Cleaning Preparations

  • Ensure the homogenizer is switched off and safely disconnected from the power supply.
  • Wear appropriate Personal Protective Equipment (PPE), including gloves, goggles, and aprons.
  • Remove any remaining product from the homogenizer.
  • Identify and remove any detachable parts for separate cleaning.

5.2 Initial Rinsing

  • Flush the homogenizer chamber and blades with warm purified water.
  • Drain the water completely before proceeding to detergent cleaning.

5.3 Cleaning Process

5.3.1 Detergent Cleaning

  • Prepare a cleaning solution using an
approved detergent.
  • Circulate the solution through the homogenizer system for 15 minutes.
  • Scrub internal and external surfaces with soft brushes.
  • Ensure the removal of any ointment residues from the homogenization chamber.
  • 5.3.2 High-Pressure Rinsing

    • Use high-pressure purified water to thoroughly rinse detergent residues.
    • Repeat the rinsing process until all traces of detergent are removed.

    5.3.3 Final Sanitization

    • Apply an approved sanitizing agent (e.g., 70% ethanol or peracetic acid solution).
    • Allow sufficient contact time (10-15 minutes) for effective disinfection.
    • Perform a final rinse with purified water to remove sanitizing residues.

    5.4 Post-Cleaning Inspection

    • Conduct a visual inspection to ensure no residues remain.
    • Perform swab testing to verify microbial cleanliness.
    • Record the results in the Cleaning Log.

    5.5 Documentation and Approval

    • Log all cleaning activities in the Cleaning Record.
    • QA personnel must review and approve the cleaning before the next batch.
    • Store records for compliance audits.

    6. Abbreviations

    • GMP – Good Manufacturing Practices
    • QA – Quality Assurance
    • QC – Quality Control
    • PPE – Personal Protective Equipment

    7. Documents

    • Cleaning Log (Annexure-1)
    • Cleaning Validation Report (Annexure-2)

    8. References

    • WHO GMP Guidelines for Pharmaceutical Manufacturing
    • 21 CFR Part 211 – Current Good Manufacturing Practices
    • ICH Q7 Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients

    9. SOP Version

    Version 2.0

    10. Approval Section

    Prepared By Checked By Approved By
    Signature
    Date
    Name
    Designation
    Department

    11. Annexures

    Annexure-1: Cleaning Log

    Date Homogenizer ID Cleaning Solution Used Sanitization Agent Verified By
    01/02/2025 HM-101 Detergent Solution 70% Ethanol QA Officer
    02/02/2025 HM-102 Alkaline Cleaner Peracetic Acid QA Officer

    Annexure-2: Cleaning Validation Report

    Date Homogenizer ID Swab Test Result Microbial Limits Final Status Approved By
    01/02/2025 HM-101 Pass Within Limit Approved QA Head
    02/02/2025 HM-102 Pass Within Limit Approved QA Head

    12. Revision History:

    Revision Date Revision No. Details of Revision Reason for Revision Approved By
    01/01/2024 1.0 Initial Version New SOP QA Head
    01/02/2025 2.0 Updated SOP Format Standardization of Document QA Head
    See also  Ointments: SOP for Documentation of Packed Batches - V 2.0
    Ointments V 2.0 Tags:Ointment application SOP, Ointment batch record SOP, Ointment compounding SOP, Ointment dispensing SOP, Ointment filling SOP, Ointment formulation SOP, Ointment manufacturing SOP, Ointment microbiological testing SOP, Ointment pH testing SOP, Ointment production SOP, Ointment quality control SOP, Ointment stability study SOP, Pharmaceutical ointment SOP, SOP for ointment homogenization, SOP for ointment labeling, SOP for ointment mixing, SOP for ointment packaging, SOP for ointment preparation, SOP for ointment raw material testing, SOP for ointment shelf-life determination, SOP for ointment stability testing, SOP for ointment sterilization, SOP for ointment storage, SOP for ointment testing, SOP for ointment viscosity testing

    Post navigation

    Previous Post: SOP for Immediate Quarantine of Raw Materials Suspected of Contamination – V 2.0
    Next Post: SOP for Sterilization Process Validation

    Standard Operating Procedures V 1.0

    • Aerosols
    • Analytical Method Development
    • Bioequivalence Bioavailability Study
    • Capsule Formulation
    • Clinical Studies
    • Creams
    • Data Integrity
    • Dental Dosage Forms
    • Drug Discovery
    • Environment, Health and Safety
    • Formulation Development
    • Gels
    • Good Distribution Practice
    • Good Warehousing Practices
    • In-Process Control
    • Injectables
    • Liquid Orals
    • Liposome and Emulsion Formulations
    • Lotions
    • Lyophilized Products
    • Maintenance Dept.
    • Medical Devices
    • Metered-Dose Inhaler
    • Microbiology Testing
    • Nanoparticle Formulation
    • Nasal Spray Formulations
    • Nebulizers
    • Ocular (Eye) Dosage Forms
    • Ointments
    • Otic (Ear) Dosage Forms
    • Pharmacovigilance
    • Powder & Granules
    • Purchase Departments
    • Quality Assurance
    • Quality Control
    • Raw Material Stores
    • Regulatory Affairs
    • Tablet Manufacturing
    • Rectal Dosage Forms
    • Transdermal Patches
    • Vaginal Dosage Forms
    • Validations and Qualifications

    Read SOPs in your Language:

     - 
    Bengali
     - 
    bn
    English
     - 
    en
    Gujarati
     - 
    gu
    Hindi
     - 
    hi
    Malayalam
     - 
    ml
    Marathi
     - 
    mr
    Punjabi
     - 
    pa
    Tamil
     - 
    ta
    Telugu
     - 
    te

    NEW! Revised SOPs – V 2.0

    • Aerosols V 2.0
    • Analytical Method Development V 2.0
    • API Manufacturing V 2.0
    • BA-BE Studies V 2.0
    • Biosimilars V 2.0
    • Capsules V 2.0
    • Creams V 2.0
    • Elixers V 2.0
    • Ointments V 2.0
    • Raw Material Warehouse V 2.0
    • Tablet Manufacturing V2.0

    New Publication: A must for All.

    Copyright © 2025 SOP Guide for Pharma.

    Powered by PressBook WordPress theme

    Go to mobile version